ATE526957T1 - Hemmung der biofilmbildung - Google Patents

Hemmung der biofilmbildung

Info

Publication number
ATE526957T1
ATE526957T1 AT10002928T AT10002928T ATE526957T1 AT E526957 T1 ATE526957 T1 AT E526957T1 AT 10002928 T AT10002928 T AT 10002928T AT 10002928 T AT10002928 T AT 10002928T AT E526957 T1 ATE526957 T1 AT E526957T1
Authority
AT
Austria
Prior art keywords
inhibition
biofilm formation
ybik
cysd
cysj
Prior art date
Application number
AT10002928T
Other languages
English (en)
Inventor
Gary R Eldridge
Original Assignee
Sequoia Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequoia Sciences Inc filed Critical Sequoia Sciences Inc
Application granted granted Critical
Publication of ATE526957T1 publication Critical patent/ATE526957T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT10002928T 2004-07-14 2005-07-14 Hemmung der biofilmbildung ATE526957T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58768004P 2004-07-14 2004-07-14
US60976304P 2004-09-14 2004-09-14
US11/085,279 US7604978B2 (en) 2004-07-14 2005-03-21 Inhibition of biofilm formation

Publications (1)

Publication Number Publication Date
ATE526957T1 true ATE526957T1 (de) 2011-10-15

Family

ID=35599971

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05791359T ATE462793T1 (de) 2004-07-14 2005-07-14 Hemmung von biofilmbildung
AT10002928T ATE526957T1 (de) 2004-07-14 2005-07-14 Hemmung der biofilmbildung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05791359T ATE462793T1 (de) 2004-07-14 2005-07-14 Hemmung von biofilmbildung

Country Status (8)

Country Link
US (2) US7604978B2 (de)
EP (2) EP1771558B1 (de)
AT (2) ATE462793T1 (de)
CA (1) CA2573440A1 (de)
DE (1) DE602005020303D1 (de)
DK (2) DK2213287T3 (de)
ES (2) ES2374152T3 (de)
WO (1) WO2006019926A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060264411A1 (en) * 2005-05-20 2006-11-23 Eldridge Gary R Control of biofilm formation
US20060014285A1 (en) * 2004-07-14 2006-01-19 Eldridge Gary R Methods and compositions for inhibiting biofilms
US7604978B2 (en) 2004-07-14 2009-10-20 Sequoia Sciences, Inc. Inhibition of biofilm formation
WO2006031943A1 (en) 2004-09-14 2006-03-23 Eldridge Gary R Compounds, compositions and methods for controlling biofilms and bacterial infections
US11857588B2 (en) 2005-04-05 2024-01-02 Membrane Protective Technologies, Inc. Reproductive cell maintenance system
US9919014B2 (en) * 2005-04-05 2018-03-20 Membrane Protective Technologies, Inc. Reproductive cell maintenance system
US20060228384A1 (en) * 2005-04-06 2006-10-12 Sequoia Sciences, Inc. Control of biofilm with a biofilm inhibitor
US20070014739A1 (en) * 2005-07-14 2007-01-18 Eldridge Gary R Compositions and methods for controlling biofilms and bacterial infections
PL2624702T3 (pl) 2010-10-06 2016-09-30 Kompozycje przeciwko tworzeniu biofilmów oraz sposoby ich zastosowania
US8324264B1 (en) 2011-07-22 2012-12-04 Sequoia Sciences, Inc. Inhibitors of bacterial biofilms and related methods
US9228996B2 (en) 2013-05-31 2016-01-05 Empire Technology Development Llc Method and device for detecting device colonization
US9535043B2 (en) 2013-05-31 2017-01-03 Empire Technology Development Llc Color change indicator of biofilm formation
WO2019046409A1 (en) 2017-08-30 2019-03-07 Ecolab Usa Inc. MOLECULES HAVING A HYDROPHOBIC GROUP AND TWO IDENTICAL HYDROPHILIC IONIC GROUPS AND CORRESPONDING COMPOSITIONS
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
JP7171895B2 (ja) 2018-08-29 2022-11-15 エコラボ ユーエスエー インコーポレイティド ポリアミンから誘導される多重荷電イオン性化合物およびその組成物、ならびにその調製方法
CA3110365C (en) 2018-08-29 2023-05-09 Ecolab Usa Inc. Use of multiple charged ionic compounds derived from polyamines for waste water clarification
CN112584910B (zh) 2018-08-29 2023-03-14 埃科莱布美国股份有限公司 衍生自多胺的带多个电荷的离子化合物及其组合物和其作为反相破乳剂用于油气操作的用途
US11155481B2 (en) * 2019-01-29 2021-10-26 Ecolab Usa Inc. Use of cationic sugar-based compounds for microbial fouling control in a water system
KR102486905B1 (ko) * 2019-03-05 2023-01-11 연세대학교 산학협력단 항균제 내성 균주의 내성 극복용 약학 조성물
AU2019441168B2 (en) 2019-04-16 2023-02-02 Ecolab Usa Inc. Use of multiple charged cationic compounds derived from polyamines and compositions thereof for corrosion inhibition in a water system

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996132A (en) * 1974-07-18 1976-12-07 Ortho Pharmaceutical Corporation Purification of utero-evacuant extracts from plant substances
JPS6136213A (ja) * 1984-07-27 1986-02-20 Rooto Seiyaku Kk 口腔用組成物
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
JPH06880Y2 (ja) * 1986-12-10 1994-01-05 三洋電機株式会社 基板支持装置
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US4929365A (en) * 1989-09-18 1990-05-29 Phillips Petroleum Co. Biofilm control
CA2109084C (en) * 1991-05-03 2004-02-24 John William Fisher Costerton Biofilm reduction method
US6004438A (en) * 1991-12-31 1999-12-21 3M Innovative Properties Company Biofilm reduction sterilizer
CN1067976C (zh) * 1994-12-03 2001-07-04 东国制药株式会社 积雪草酸衍生物及其制备方法和包含该衍生物的皮科制剂
US5789239A (en) * 1995-06-05 1998-08-04 Betzdearborn Inc. Composition and process for the avoidance of slime formation and/or for the removal of biofilm in water-bearing systems
US5985601A (en) * 1995-06-05 1999-11-16 Human Genome Sciences, Inc. DNA encoding human cystatin E
US5882916A (en) * 1996-02-15 1999-03-16 Nouveau Technolgies, Inc. Decontamination process
US6599714B1 (en) * 1996-03-13 2003-07-29 University Technologies International Inc. Method of growing and analyzing a biofilm
FR2750326B1 (fr) * 1996-06-28 1998-07-31 Oreal Composition cosmetique et/ou dermatologique acide contenant un poly(acide 2-acrylamido 2-methylpropane sulfonique) reticule et neutralise a au moins 90 %
AU4062497A (en) 1996-08-23 1998-03-06 Isis Pharmaceuticals, Inc. Normalization of combinatorial reactions
US6455031B1 (en) * 1997-06-18 2002-09-24 David G Davies Methods and compositions for controlling biofilm development
WO1999010017A1 (en) * 1997-08-26 1999-03-04 Board Of Regents, The University Of Texas System Chelators in combination with biocides: treatment of microbially induced biofilm and corrosion
US20020037260A1 (en) * 1997-10-16 2002-03-28 Budny John A. Compositions for treating biofilm
US5906825A (en) * 1997-10-20 1999-05-25 Magellan Companies, Inc. Polymers containing antimicrobial agents and methods for making and using same
US6555055B1 (en) * 1998-07-29 2003-04-29 Lynntech, Inc. System for preventing and remediating biofilms in dental equipment
JP2002529545A (ja) * 1998-11-06 2002-09-10 ユニベルシテ ドゥ モントリオール バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液
US7326542B2 (en) * 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
US6264926B1 (en) * 1999-02-12 2001-07-24 Council Of Scientific And Industrial Research Formulation useful as a natural herbal tooth powder
US6080323A (en) * 1999-02-17 2000-06-27 Nalco Chemical Company Method of removing biofilms from surfaces submerged in a fouled water system
US6369101B1 (en) * 1999-02-26 2002-04-09 Regents Of The University Of Minnesota Therapeutic method to treat herpes virus infection
US6395189B1 (en) * 1999-03-01 2002-05-28 Polymer Ventures, Inc. Method for the control of biofilms
US6498862B1 (en) * 1999-05-18 2002-12-24 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Evaluation of biofilms and the effects of biocides thereon
US20040033549A1 (en) * 1999-09-03 2004-02-19 Greenberg E. Peter Quorum sensing signaling in bacteria
US6399115B2 (en) * 1999-09-10 2002-06-04 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
AU7486100A (en) * 1999-09-14 2001-04-17 James W. Chandler System and method of controlling microorganism and biofilms
AU2001256965A1 (en) * 2000-03-23 2001-10-03 Influx, Inc. Bactericidal antimicrobial methods and compositions for use in treating gram positive infections comprising an antibiotic potentiator having acyl hydrazide oxy amide or 8-hydroxy quinoline structure
US6596505B2 (en) * 2000-04-17 2003-07-22 University Technologies International, Inc. Apparatus and methods for testing effects of materials and surface coatings on the formation of biofilms
US6267897B1 (en) * 2000-05-04 2001-07-31 Nalco Chemical Company Method of inhibiting biofilm formation in commercial and industrial water systems
WO2002050001A2 (en) * 2000-12-20 2002-06-27 Warner-Lambert Company Non-halogenated naphthol compounds and antimicrobial compositions containing the same
FR2819410B1 (fr) * 2001-01-18 2003-02-21 Oreal Composition cosmetique irisee et ses utilisations
WO2002085295A2 (en) * 2001-04-20 2002-10-31 The University Of Iowa Research Foundation Methods and compositions for the modulation of biofilm formation
US6585961B1 (en) * 2001-11-30 2003-07-01 Richard F. Stockel Antimicrobial compositions
DE10204390A1 (de) * 2002-02-04 2003-08-14 Bayer Cropscience Ag Disubstituierte Thiazolylcarboxanilide
US6669929B1 (en) * 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
US20050137259A1 (en) * 2003-09-22 2005-06-23 Use- Techno Corporation Insulin secretion potentiator
US20060014285A1 (en) * 2004-07-14 2006-01-19 Eldridge Gary R Methods and compositions for inhibiting biofilms
US20060264411A1 (en) * 2005-05-20 2006-11-23 Eldridge Gary R Control of biofilm formation
WO2006010147A2 (en) 2004-07-14 2006-01-26 Eldridge Gary R Control of biofilm formation
US7604978B2 (en) 2004-07-14 2009-10-20 Sequoia Sciences, Inc. Inhibition of biofilm formation
WO2006031943A1 (en) 2004-09-14 2006-03-23 Eldridge Gary R Compounds, compositions and methods for controlling biofilms and bacterial infections
WO2006102255A1 (en) 2005-03-21 2006-09-28 Sequoia Sciences, Inc. Inhibition of biofilm formation
US20060228384A1 (en) * 2005-04-06 2006-10-12 Sequoia Sciences, Inc. Control of biofilm with a biofilm inhibitor
US20070014739A1 (en) * 2005-07-14 2007-01-18 Eldridge Gary R Compositions and methods for controlling biofilms and bacterial infections

Also Published As

Publication number Publication date
CA2573440A1 (en) 2006-02-23
US20100041753A1 (en) 2010-02-18
DK2213287T3 (da) 2012-01-02
EP2213287A1 (de) 2010-08-04
ES2374152T3 (es) 2012-02-14
EP1771558A2 (de) 2007-04-11
EP1771558A4 (de) 2007-08-08
DE602005020303D1 (de) 2010-05-12
DK1771558T3 (da) 2010-07-05
WO2006019926A2 (en) 2006-02-23
ATE462793T1 (de) 2010-04-15
ES2342411T3 (es) 2010-07-06
EP1771558B1 (de) 2010-03-31
WO2006019926A3 (en) 2006-05-04
US7604978B2 (en) 2009-10-20
US20060014290A1 (en) 2006-01-19
EP2213287B1 (de) 2011-10-05

Similar Documents

Publication Publication Date Title
ATE526957T1 (de) Hemmung der biofilmbildung
AU2017224999B2 (en) Use
BRPI0511770A (pt) métodos e composições para a inibição da expressão de genes
EP1824872A4 (de) Rnai-modulation von mll-af4 und verwendungen dafür
EA200901653A1 (ru) ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC
WO2009102983A3 (en) Efficient induction of pluripotent stem cells using small molecule compounds
EP1942948A4 (de) Zusammensetzungen und verfahren zur hemmung der expression des nav1.8-genes
DE602006015484D1 (de) Verwendung der crispr assoziierten gene (cas)
EP1750771A4 (de) Pankreasinsel-mikro-rna und verfahren zu ihrer unterdrückung
PL2126020T3 (pl) Hydrofobowo modyfikowane polialkilenoiminy jako inhibitory przenoszenia barwnika
MX2009009071A (es) Cultivos con resistencia mejorada a fagos.
NZ590750A (en) Methods and compositions for improving the production of products in microorganisms, especially clostridium phytofermentans
WO2008054475A3 (en) Neuraminidase inhibitors and uses thereof
BR0308351A (pt) molécula de ácido nucleico isolada, planta transgênica, e, métodos para produzir uma planta transgênica e para selecionar uma planta contendo uma molécula de ácido nucleico
WO2008116920A3 (de) 17beta-hydroxysteroid-dehydrogenase-typ1-inhibitoren zur behandlung hormonabhängiger erkrankungen
DK2089516T3 (da) Fremgangsmåder til at forbedre indføringen af DNA i bakterielle celler
DE602007008067D1 (de) Verfahren zur herstellung von terpenen und mep-transformierte mikroorganismen dafür
WO2007014077A3 (en) Rnai modulation of the rho-a gene and uses thereof
CO6640205A2 (es) Microorganismos y metodos para la biosintesis de p-toluato y tereftalato
WO2006138606A3 (en) Cell signaling genes and related methods
DK2029732T3 (da) Chloramphenicolresistensselektion i Bacillus licheniformis
MX2009008335A (es) Mezclas de tinturas azoicas fibrorreactivas.
TW200621744A (en) Mercaptoamides as histone deacetylase inhibitors
ATE435011T1 (de) Verwendung von morpholino-verbindungen zur verhinderung bakteriellen befalls
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties